Delta-5-desaturase: A novel therapeutic target for cancer management
Authors:
Open Access
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Translational Oncology
- Vol. 14 (11) , 101207
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1R15CA195499-01A1)
This publication has 136 references indexed in Scilit:
- Prostaglandin E2 promotes Th1 differentiation via synergistic amplification of IL-12 signalling by cAMP and PI3-kinaseNature Communications, 2013
- The first characterization of free radicals formed from cellular COX-catalyzed peroxidationFree Radical Biology and Medicine, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Multiple roles of dihomo-γ-linolenic acid against proliferation diseasesLipids in Health and Disease, 2012
- Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeuticsNature Nanotechnology, 2011
- Characterization of free radicals formed from COX-catalyzed DGLA peroxidationFree Radical Biology and Medicine, 2011
- Sesamin Manifests Chemopreventive Effects through the Suppression of NF-κB–Regulated Cell Survival, Proliferation, Invasion, and Angiogenic Gene ProductsMolecular Cancer Research, 2010
- Urinary Prostaglandin E2 Metabolite and Gastric Cancer Risk in the Shanghai Women's Health StudyCancer Epidemiology, Biomarkers & Prevention, 2009
- ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy MachineryMolecular Biology of the Cell, 2009
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005